Cargando…
1361. The association between antibody responses and prolonged viable SARS-CoV-2 shedding in immunocompromised patients: a prospective cohort study
BACKGROUND: Immunocompromised patients have been shown to have prolonged SARS-CoV-2 viral shedding. However, there are limited data on the longitudinal association between immune response and viable virus shedding in immunocompromised patients. Thus, we aimed to investigate the relationship between...
Autores principales: | Lim, So Yun, Kim, Jun-Won, Kim, Ji Yeun, Kang, Sung-Woon, Jang, Choi-Young, Chang, Eui Jin, Yun, Sung-Cheol, Yang, Jeong-Sun, Kim, Kyung-Chang, Jang, Hee-Chang, Kim, Dasol, Shin, Younmin, Lee, Joo-Yeon, Kim, Sung-Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679128/ http://dx.doi.org/10.1093/ofid/ofad500.1198 |
Ejemplares similares
-
Characteristics and risk factors of prolonged viable virus shedding in immunocompromised patients with COVID-19: a prospective cohort study
por: Kang, Sung-Woon, et al.
Publicado: (2023) -
464. Whole Genome Sequencing and Mutation Analysis of SARS-CoV-2 in the Immunocompromised Patients with Persistent SARS-CoV-2 Shedding
por: Chang, Eui Jin, et al.
Publicado: (2023) -
Clinical scoring system to predict viable viral shedding in patients with COVID-19
por: Kang, Sung Woon, et al.
Publicado: (2022) -
Mutational analysis of severe acute respiratory syndrome coronavirus 2 in immunocompromised patients with persistent viral detection using whole genome sequencing
por: Chang, Euijin, et al.
Publicado: (2023) -
Anxiolytic Effects of the MCH1R Antagonist TPI 1361-17
por: Lee, Cheol, et al.
Publicado: (2010)